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Abstract: Histological changes in bone structure were induced at 12 weeks by experimental administration of bisphosphonates, which
have been associated with osteonecrosis of the jaws. The purpose of this study was to determine the effect of local administration of
bisphosphonate on bone formation in rats. Surgically created bone defects were evaluated at 12 weeks by histological examination after
bisphosphonate administration. Fifteen Wistar rats that underwent surgery to create a bone defect at the right femur were divided
in 3 groups: 2 experimental groups and a control group. The 1st experimental group received bisphosphonate as a single 1-mL dose
into the bone defect, the 2nd experimental group received 1 mL of bisphosphonate as a 10-day fractionated dose, and the control
group comprised rats who did not receive any bisphosphonate. At 12 weeks after the injection, new bone tissue was collected and a
histological examination was performed. At 12 weeks after the bisphosphonate administration, bone repair processes were found in
both the experimental and control groups. The bone continuity in the intervention area was ensured by a continuous layer of bone tissue.
Compared with the control, the repair processes were significantly more advanced in the experimental groups, the layer of bone tissue
covering the bone defect being thicker and more consolidated and the trabeculae from the Haversian canal being thicker and denser.
External and internal consolidation structures were present in animals from all of the groups. Bisphosphonate had a positive influence
on bone formation. The stimulatory effect of the bisphosphonate increased with the number of administered doses.
Key words: Bisphosphonate, rat, bone remodeling, histology

1. Introduction
There has been an increasing number of reports published
on patients with osteonecrosis of the jaws associated with
the use of bisphosphonates (1–5).
Although evidence suggests that the duration of and
preparation for bisphosphonate treatment are important
indicators of risk for jaw osteonecrosis, many guidelines
continue to categorize risk according to the route by which
the bisphosphonate is administrated (6). The mechanism
of bisphosphonate action is attributed to its implication of
osteoblast activity (7).
The aims of this study were: 1) to describe the
histopathologic features at 12 weeks after bisphosphonate
administration in a rat model, and 2) to identify the effects
of bisphosphonate on bone remodeling.
2. Materials and methods
Following approval from the institutional ethical
committee (the procedures and protocol were approved
* Correspondence: mbaciut@yahoo.com

50

by the institutional review board of the university and by
the ethics committee, certificate number 172/2010), we
selected 15 Wistar rats, 5 in the control group and 10 in
the experimental group. All of the rats underwent surgery
to create a bone defect with a 1.5-mm-diameter bone-bur
at the right femur transcortical through the Haversian
canal. Rats from the experimental group were divided into
2 subgroups: group A, which received zoledronic acid,
a commonly used bisphosphonate on the jaw bone, in a
1-mL single dose in the bone marrow during surgery, and
group B, which received zoledronic acid in 1-mL divided
doses daily at 0.1 mL for 10 days. The control group did
not receive any bisphosphonate.
The pieces were fixed in 10% formalin for 7 days
and then decalcified in 7% trichloroacetic acid solution,
changed several times. They were then inserted into a
mixture of 70% alcohol and glycerin for 12 h and then 2
glycerin baths for 24 h each, followed by 2 absolute alcohol
baths for 45 min each. Next, they were passed through 2
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baths of butyl alcohol for 24 h each and 3 baths of melted
paraffin at 56 °C, and finally cast in paraffin blocks.
Division of the samples was made with

a microtome
(Leica Biosystems, Germany) at a thickness of 5 µm; the
sections were displayed on a glass slab that was previously
coated with a thin layer of Meyer albumin. They were
then submitted to 45 °C for 24 h. Probes were colored by
Goldner’s trichrome method as follows: the slides were
decerated in xylene, with 2 changes for 2 min each; placed
in absolute alcohol (95% alcohol) with 2 changes for 2 min
each; rinsed in distilled water; inserted in Lugol’s solution
for 5 min; rinsed with distilled water and inserted into a 5%
solution of sodium thiosulfate for 5 min; rinsed again with
distilled water; placed in Weigert’s hematoxylin for 10 min;
washed in running tap water for 10 min; rinsed in distilled
water and stained in Ponceau acid fuchsin for 5 min;
washed in 1% acetic acid and placed in phosphomolybdic
acid–orange G solution until the collagen was decolorized;
rinsed in 1% acetic acid for 30 s; stained in light green stock
solution for 5 min; and rinsed in 1% acetic acid for 5 min.
The slices were dehydrated in 95% alcohol and absolute
alcohol with 3 changes each and were then cleared in
xylene with 3 changes. A cover glass was mounted with
appropriate medium (refractive index: 1.48–1.56). All of
the samples were subjected to optic microscopic (Olympus
BX41) examination at 12 weeks to evaluate differences in
the bone structure.
3. Results
Microscopic examination of serial sections of the
intervention performed at 12 weeks after the start of the
experiment showed bone repair processes in all of the
studied animals. These were still developing, which showed
that the intervention area was relatively well consolidated.
Pending completion of the repair process, a certain period
of time must pass. There were differences between the 2
experimental groups, and between them and the control
group, regarding the stages reached by the recovery and
consolidation processes of bone repair in the intervention
area.
In the control group, the surface area of the defect
was occupied by primary bone, which closed the
communication with the exterior (Figure 1a), and the
Haversian canal was occupied in the defect area by
relatively young spongious bone. The junction area
between the surface of the bone defect and the newly
formed bone could be assessed quite well. The newly
formed bone occupied the surface area of the defect and
extended as trabeculae into the depth of the periosteum
and to the external area beneath the periosteum over a
certain distance (Figure 1b). This layer of spongious bone
tissue proliferated beneath the periosteum reinforced the
bone wall, increasing its strength gradually compared to

the strength of the adjacent bone. From the surface bone
layer proliferated into the bone defect, bone trabeculae
initiated into the depth, occupying the Haversian canal
almost entirely with a few remaining gaps or areas
occupied by the connective tissue (Figure 1c), these also
being involved in the bone repair processes (no trend of
fibrosis).
Gaps were more common in the depth of the area of
intervention, and the trabeculae were thinner and highly
polymorphic (Figure 1d). In the areas where the bone
wall was thickened by periosteum bone proliferation,
it occupied a maximum thickness area of about 30% of
the total thickness of the bone wall (Figure 1e). It had an
intermediate structure between spongious and compact
bone, which indicated that it initially proliferated spongious
bone, which gradually transformed into compact bone, a
process that was not yet completed.
In experimental group A, the surface area of 
the
defect was occupied by primary bone that closed the
communication with the exterior, and the Haversian canal
was occupied by bone trabeculae in the process of bone
restructuring (Figure 2a), the areola between them being
occupied by bone marrow. Trabeculae existing in the depth
of the bone defect were relatively thick and fully occupied
the cavity of the bone defect area (Figure 2b). Areolas
from this bone were filled with bone marrow of normal
structure. Newly formed bone covered the bone from the
surface of the defect area by a thick layer of spongious
periosteum bone with tendency of remodeling to compact
bone (Figure 2c).
Furthermore, this bone derived from the periosteum
extended on the exterior side of the bone in the defect
area, covering practically the whole circumference with its
thickness decreasing as it moved away from the border of
the hole (Figure 2d). In some areas, its thickness was very
large, exceeding up to 50% of the wall thickness (Figure 2e)
with a spongious appearance on almost 70% of its internal
side, showing that it was still in the process of proliferation
and remodeling to compact bone.
In experimental group B, the surface area of the
 bone
defect was occupied by the primary bone, which closed the
external communication. The Haversian canal was filled
with bone trabeculae that were in the process of repair and
the areola separated from them contained bone marrow
with a typical structure (Figure 3a). The bone trabeculae
were relatively thick, in the mid-surface of the defect (Figure
3b) and in the depth of the defect (Figure 3c), indicating
that the repair and strengthening of the experimental bone
defect were quite advanced, although still not completed.
In the animals of this group, the bone wall was doubled
by bone periosteum bone from the consolidation process,
which disposed its entire circumference, although its
thickness was not as great on the whole surface (Figure
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Figure 1. Control group at 12 weeks from the beginning of the experiment (Goldner’s trichrome, 4×): a) 1, the primary proliferated
bone at the surface of the experimental bone defect and 2, the bone trabeculae in the Haversian canal; b) 1, the boundary between the
existent bone and the newly formed bone at the periphery of the experimental bone defect and 2, the periosteum anchorage bone; c) 1,
the periosteum and 2, the connective tissue from the surface area of the experimental bone defect; d) 1, the polymorph bone trabeculae
and 2, the areolas partially occupied by bone marrow; e) the periosteum bone.
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Figure 2. Experimental group treated with a single dose of bisphosphonate at 12 weeks from the beginning of the experiment (Goldner’s
trichrome, 2×): a) 1, the defect margins and 2, the bone trabeculae proliferated in the Haversian canal; b) 1, bone trabeculae well
anchored in the depth of the experimental bone defect; c) 1, the periosteum bone, primary at the surface and 2, spongious bone in the
depth; d) 1, different thicknesses of the periosteum anchorage bone in relation to the distance to the defect; and e) 1, the periosteum
anchorage bone occupying more than 50% of the total bone thickness with a, compact bone and b, spongious bone.
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3d). In the thickest portion, this bone exceeded 50% of the
wall thickness, its structure being compact in the external
two-thirds and spongious in the internal third (Figure 3e),
suggesting that the processes of bone repair were quite
advanced (basically the most advanced from all of the
studied animals) but that there was some time needed for
completion of bone repair processes.
4. Discussion
In the control group, the bone continuity in the
intervention area was assured by a continuous layer of bone
tissue, which interrupted the communication with the
outside. The spongious bone in the process of proliferation
represented the internal consolidation “armor” trying to
rebuild bone strength in the intervention area. In the area
with the maximum thickness, the periosteum bone collar
reached about 30% of the total thickness of the bone wall.
Hence, the bone had continuity in the intervention area
and some resistance given by the internal and external
building structures.
In experimental group A, the defect was covered by a
layer of compact bone, which ensured bone continuity in
the intervention area. Compared with controls, the repair
processes were significantly more advanced, the layer of
bone tissue covering the bone defect being thicker and
more consolidated and trabeculae from the Haversian
canal being thicker and denser. Areolas between the
trabeculae were occupied by bone marrow with normal
bone structure. The external consolidation components
were significantly thicker and exceeded 50% of the total
bone wall thickness at its thickest portion. The structure of
this bone was spongious (trabeculae) on more than half of
the internal side, suggesting that it was still in the process
of proliferation and, specifically, remodeling to compact
bone.
In group B, the surface area of the
 bone defect was
occupied by a more consistent continuous bone layer with
a thickness that was the largest of all of the studied groups.
Even if the thickness was not significantly larger compared
with the group treated with a dose of bisphosphonate,
its structure was found to be in the most advanced
remodeling and consolidation stage of all of the studied
groups. However, the repair and strengthening processes
of the experimental bone defect were not yet finalized.
Following the basics of the bone repair process, we
could assess the modality and speed of the repair processes
in the animals of all of the studied groups. Although these
processes were running somewhat parallel, the restoration
of the continuity of the bone wall and the interruption of
the communication between the Haversian canal wall and
the exterior of the bone represented the highest priority.
The layer covering the bone defect was slightly thickened
and markedly consolidated in the animals of all of the
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studied groups, with the differences among groups being
largely maintained. The emergence and evolution of the
external and internal building structures were slightly
different. The external structures enhancing the bone wall
occurred relatively early and had the same starting point,
the periosteum near the experimental defect.
Based on the bone-forming cells from the inner layer of
the periosteum, osteoblasts developed. These were actively
involved in bone building that extended in 2 directions:
towards the bone defect to form the layer for restoring its
continuity and as a thin layer between the periosteum and
the compact bone surrounding the defect (like a collar).
Proliferation was not identical in the 2 directions; bone
that tended to cover the defect proliferated significantly
faster than the collar-building bone such that the latter was
relatively thin and did not extend the entire circumference
of the bone. This periosteum consolidation bone, although
it was not very developed yet in any of the studied groups,
was different among the groups. The most developed was
found to be present in group B, followed by group A and
the control group.
The situation was different regarding the strengthening
of the internal structures. Animals from the control group
showed the development of the internal structure as being
in an early stage of consolidation. There were thin strips of
bone that penetrated into a certain distance of the internal
wall of the experimental bone defect at its periphery
(mainly periosteum in origin and partly endosteum).
There were also a few contours of short and infrequent
trabeculae that did not yet assess stable relationships. This
bone represented the early stage of organization of the
internal building structures, but did not yet significantly
participate in the restoring of the bone wall resistance. The
situation was different regarding the experimental groups,
which showed polymorphic branched trabeculae (in the
process of formation and consolidation), which occupied
most of the Haversian canal. There remained only a few
bone gaps unoccupied by trabeculae, which were found to
be slightly more in group A compared to group B. These
bone trabeculae represented the consolidation structure of
the defect zone, which was comparable to a scaffold, being
organized on the lines of force direction. The existence
of internal building structures, which were far more
organized in the experimental groups compared with the
control group, clearly showed that the bisphosphonate
significantly stimulated bone proliferation. In the
experimental groups, bone strength was restored to some
extent. However, a long time period will be needed until
full recovery of the bone resistance is achieved.
External and internal consolidation structures were
found in the animals from all of the groups. Thus, external
structures were found in the form of a collar bone of uneven
thickness, ordered along the entire bone circumference.
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Figure 3. Experimental group treated with 10 doses of bisphosphonate at 12 weeks from the beginning of the experiment (Goldner’s
trichrome, 10×): a) 1, defect margins, 2, proliferated bone in the experimental defect area, and 3, the periosteum anchorage bone; b) 1,
compact bone from the surface of the experimental bone defect, 2, thick bone trabeculae from the surface of the experimental defect,
and 3, the polymorph areolas; c) 1, bone trabeculae from the deep area of the experimental defect and 2, areolas with bone marrow; d)
1, the periosteum anchorage bone and 2, the bone wall; e) 1, bone recovery towards compact bone and 2, spongious bone.
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Among the groups, there were differences regarding the
thickness and degree of bone consolidation. In the control
group, the periosteum bone collar was 30% of the bone
wall thickness in its thickest area, while it occupied 50% in
the experimental groups.
There were no significant differences found regarding
the bone thickness between the experimental groups,
but structurally, it was a relatively compact bone. In
experimental group A, the bone consisted of 30% compact
bone and 70% spongious bone, while in experimental
group B, the compact bone occupied approximately
70%. These differences showed that the thickness of the
periosteum collar will not exceed half of the bone thickness.
It will gradually transform into compact bone. The rate of
compact bone/spongious bone was in favor of group B. This
showed that the stimulatory effect of the bisphosphonate
increased with the number of administered doses.
Bone strengthening of the internal structures was
present in all of the groups, but there were marked
differences in their levels of organization. These aspects
suggested that the experimental groups ensured the best
mechanical strength. However, the finalization of the
postoperative bone healing will take some time.
The bone repair processes occurred normally in all
of the studied groups. No pathological processes were
reported. This showed that not only was the drilling of
the holes done correctly, but other conditions related

to surgery were also good (anesthesia, incision, and
suture). The natural bone repair process occurred without
complications.
Other studies showed that bisphosphonates inhibited
bone resorption in vitro (8). The reduction in bone
turnover induced by traditional bisphosphonates was
explained as being due to the reduction in the extent of
osteoblast-covered surfaces (9). Previous evidence has
shown that where osteoblasts are present, more bone
is made, as indicated by an increase in the wall bone
thickness of animals under long-term treatment with
bisphosphonates (10–12). Some authors have suggested
that zoledronate could be toxic to fibroblasts (13), which
we could not verify.
In conclusion, bisphosphonate had a positive
influence on bone formation. The stimulatory effect
of the bisphosphonate increased with the number of
administered doses. The new bone area increased under
the influence of bisphosphonate, a single administration
shortening the healing bone period compared to multiple
dose administration.
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